Ligand validation:4XNK

PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XNK_PE5_A_503	1%	83%	0.695	0.918	0.26	0.51	-	-	1	0	30%	0.2963
8Q2O_PE5_A_504	57%	68%	0.108	0.963	0.57	0.66	-	-	0	0	56%	0.45
4AFK_PE5_A_1516	53%	57%	0.103	0.942	0.41	1.24	-	-	0	0	56%	0.5556
8PZ4_PE5_A_1017	30%	83%	0.175	0.919	0.53	0.26	-	-	0	0	56%	0.5556
5IYU_PE5_A_505	22%	63%	0.17	0.909	0.96	0.48	-	-	0	0	30%	0.2963
5D5D_PE5_A_511	14%	86%	0.286	0.963	0.47	0.26	-	-	2	0	30%	0.2963
1WMA_PE5_A_310	89%	64%	0.08	0.957	0.71	0.66	-	-	1	0	100%	1
6QF2_PE5_A_418	72%	86%	0.128	0.952	0.53	0.19	-	-	0	0	100%	0.47
5ZRU_PE5_C_601	69%	74%	0.099	0.911	0.55	0.45	-	-	1	0	100%	1
4MUU_PE5_B_217	62%	72%	0.12	0.911	0.78	0.3	-	-	1	0	100%	0.53

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.